JD Supra

Method of Treatment Claim’s Limiting Preamble Must Satisfy the Written Description Requirement

On March 13, 2025, the U.S. Court of Appeals for the Federal Circuit issued a decision in the case of In Re: Xencor, Inc. 1 In this Appeal from the Appeals Review Panel of the Patent Trial and Appeal ...
JD Supra

Federal Circuit Clarifies Written Description and Enablement Standards for Method-of-Treatment Patent Claims Using a Well-Known Antibody Genus

On April 16, 2026, a Federal Circuit panel in Teva Pharms. Int'l GmbH v. Eli Lilly & Company, No. 24-1094, held that patent claims directed to ...
The National Law Review

Seeking Grace- Pursuing Method of Treatment Claims in View of Clinical Trial Related Disclosures

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...